Pharmacologic Approaches to Improve Mitochondrial Function in AKI and CKD

Area of Science:

• Nephrology
• Mitochondrial Biology
• Cellular Metabolism

Background:

• Acute kidney injury (AKI) and chronic kidney disease (CKD) are significant health concerns with high morbidity and mortality.
• Kidney function relies on energy-intensive processes, with fatty acids as primary substrates.
• Mitochondrial dysfunction and impaired fatty acid oxidation are implicated in various kidney diseases.

Purpose of the Study:

• To review ATP production and energy demands in the kidney.
• To summarize evidence of mitochondrial dysfunction in AKI and CKD.
• To present novel therapeutic strategies targeting mitochondrial protection and cellular bioenergetics.

Main Methods:

• Review of preclinical and clinical evidence on mitochondrial dysfunction in AKI and CKD.
• Analysis of therapeutic strategies evaluated in animal models of AKI and CKD.

Main Results:

• Mitochondrial dysfunction is a common factor in diverse causes of AKI and CKD.
• Targeting upstream mitochondrial and bioenergetic processes may be advantageous.
• Therapeutic strategies focus on mitochondria protection and cellular energy production.

Conclusions:

• Mitochondrial dysfunction is central to AKI and CKD pathogenesis.
• Interventions aimed at improving kidney bioenergetics and mitochondrial function show promise.
• Targeting cellular energy metabolism offers a novel therapeutic avenue for kidney disease.